Mabelio (Ceftobiprole Medocaril Sodium)

Mabelio is an intravenous antibiotic containing Ceftobiprole Medocaril Sodium, used to treat bacterial infections. This medication is designed for hospital use and is manufactured by Correvio.

Mabelio is primarily used for the treatment of bacterial infections, including those resistant to other antibiotics. It is often prescribed for complicated skin and skin structure infections, as well as community-acquired pneumonia. The active ingredient, Ceftobiprole Medocaril Sodium, works by stopping the growth of bacteria.

Common effects of Mabelio may include nausea, headache, and diarrhea. Some patients might experience infusion-related reactions such as flushing or fever. These effects are generally mild and temporary, but severe reactions should be reported to a healthcare provider.

Mabelio should be administered under medical supervision due to its intravenous route. Patients with a history of allergic reactions to antibiotics should use it with caution. It is important to follow the prescribed dosage and administration instructions to minimize potential risks.

Mabelio may interact with other medications, including certain antibiotics and blood thinners. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect liver function should be avoided.